{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:06:10Z","timestamp":1789049170390,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>STAT3 gain-of-function (GOF) syndrome is a multi-organ primary immune regulatory disorder characterized by early onset autoimmunity. Patients present early in life, most commonly with lymphoproliferation, autoimmune cytopenias, and growth delay. However, disease is often progressive and can encompass a wide range of clinical manifestations such as: enteropathy, skin disease, pulmonary disease, endocrinopathy, arthritis, autoimmune hepatitis, and rarely neurologic disease, vasculopathy, and malignancy. Treatment of the autoimmune and immune dysregulatory features of STAT3-GOF patients relies heavily on immunosuppression and is often challenging and fraught with complications including severe infections. Defects in the T cell compartment leading to effector T cell accumulation and decreased T regulatory cells may contribute to autoimmunity. While T cell exhaustion and apoptosis defects likely contribute to the lymphoproliferative phenotype, no conclusive correlations are yet established. Here we review the known mechanistic and clinical characteristics of this heterogenous PIRD.<\/jats:p>","DOI":"10.3389\/fped.2022.770077","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T06:32:15Z","timestamp":1675924335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["STAT3 gain-of-function syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Tiphanie P.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Forbes Satter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10875-021-00980-1","article-title":"The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb1662","article-title":"Human inborn errors of immunity: an expanding universe","volume":"5","author":"Notarangelo","year":"2020","journal-title":"Sci Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","author":"Leiding","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108316","DOI":"10.1016\/j.clim.2019.108316","article-title":"Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity","volume":"210","author":"Jagle","year":"2020","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000456544","article-title":"Short stature in a boy with multiple early-onset autoimmune conditions due to a STAT3 activating mutation: could intracellular growth hormone signalling be compromised?","volume":"88","author":"Sediva","year":"2017","journal-title":"Horm Res in Paediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jaci.2019.11.042","article-title":"Erythropoiesis defect observed in STAT3 GOF patients with severe anemia","volume":"145","author":"Mauracher","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"20037","DOI":"10.18632\/oncotarget.5042","article-title":"A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation","volume":"6","author":"Wienke","year":"2015","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.celrep.2017.03.055","article-title":"An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation","volume":"19","author":"Saarimaki-Vire","year":"2017","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10875-020-00914-3","article-title":"Life-Saving, dose-adjusted, targeted therapy in a patient with a STAT3 gain-of-function mutation","volume":"41","author":"Sarfati","year":"2021","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy and Clin Immunol in Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.mce.2018.01.016","article-title":"Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations","volume":"473","author":"Gutierrez","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-021-09225-0","article-title":"Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8\/STAT3, KIT\/STAT3, and IL-2\/CD25\/treg axes","author":"Marega","year":"2021","journal-title":"Immunol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","article-title":"STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds","volume":"181","author":"Nabhani","year":"2017","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1053\/j.gastro.2018.11.065","article-title":"Efficacy of ruxolitinib therapy in a patient with severe enterocolitis associated with a STAT3 gain-of-function mutation","volume":"156","author":"Parlato","year":"2019","journal-title":"Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fped.2017.00049","article-title":"Up, down, and all around: diagnosis and treatment of novel STAT3 variant","volume":"5","author":"Weinreich","year":"2017","journal-title":"Front Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.3324\/haematol.2018.202374","article-title":"Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression","volume":"104","author":"Todaro","year":"2019","journal-title":"Haematologica"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 Signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 Mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13075-015-0526-4","article-title":"Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response","volume":"17","author":"Kikuchi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MOH.0000000000000206","article-title":"Signal transducer and activator of transcription 3: a year in review","volume":"23","author":"Forbes","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.clinthera.2017.01.004","article-title":"Tocilizumab promotes regulatory T-cell alleviation in STAT3 gain-of-function-associated multi-organ autoimmune syndrome","volume":"39","author":"Khoury","year":"2017","journal-title":"Clin Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210759","article-title":"A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance","volume":"218","author":"Warshauer","year":"2021","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.immuni.2022.11.001","article-title":"STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D(hi) CD8(+) T cell dysregulation and accumulation","volume":"55","author":"Masle-Farquhar","year":"2022","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.4049\/jimmunol.2100920","article-title":"Cutting edge: systemic autoimmunity in murine STAT3 gain-of-function syndrome is characterized by effector T cell expansion in the absence of overt regulatory T cell dysfunction","volume":"209","author":"Woods","year":"2022","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.162695","article-title":"A human STAT3 gain-of-function variant confers T cell dysregulation without predominant treg dysfunction in mice","volume":"7","author":"Schmitt","year":"2022","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01388-5","article-title":"Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child","author":"Ogishi","year":"2021","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.2337\/db16-0867","article-title":"An activating mutation in STAT3 results in neonatal diabetes through reduced insulin synthesis","volume":"66","author":"Velayos","year":"2017","journal-title":"Diabetes"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1164\/rccm.201707-1500IM","article-title":"STAT3 Gain of function: a new kid on the block in interstitial lung diseases","volume":"197","author":"Fabre","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/rheumatology\/key308","article-title":"STAT3 Gain of function: a new aetiology of severe rheumatic disease","volume":"58","author":"Giovannini-Chami","year":"2019","journal-title":"Rheumatol (Oxford, England)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/1093526619890734","article-title":"Prenatal autoimmune disease, multisystem, infantile onset-like phenotype and proximal renal tubular dysplasia associated with STAT3 mutation","volume":"23","author":"Terry","year":"2020","journal-title":"Pediatr Dev Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/13816810.2019.1592202","article-title":"Papilledema from gain-of-function mutations in the STAT3 gene","volume":"40","author":"Suh","year":"2019","journal-title":"Ophthalmic Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"620046","DOI":"10.3389\/fimmu.2020.620046","article-title":"Case report: signal transducer and activator of transcription 3 gain-of-function and spectrin deficiency: a life-threatening case of severe hemolytic Anemia","volume":"11","author":"Ciullini Mannurita","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/cei.13625","article-title":"Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype","volume":"205","author":"Erdos","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jaci.2022.06.007","article-title":"STAT3-confusion-of-function: beyond the loss and gain dualism","volume":"150","author":"Lodi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.770077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T06:32:21Z","timestamp":1675924341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.770077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":42,"alternative-id":["10.3389\/fped.2022.770077"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.770077","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"article-number":"770077"}}